127 related articles for article (PubMed ID: 33301930)
1. Tocilizumab controls bone turnover in early polymyalgia rheumatica.
Carvajal Alegria G; Garrigues F; Bettacchioli E; Loeuille D; Saraux A; Cornec D; Devauchelle-Pensec V; Renaudineau Y
Joint Bone Spine; 2021 May; 88(3):105117. PubMed ID: 33301930
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study.
Devauchelle-Pensec V; Berthelot JM; Cornec D; Renaudineau Y; Marhadour T; Jousse-Joulin S; Querellou S; Garrigues F; De Bandt M; Gouillou M; Saraux A
Ann Rheum Dis; 2016 Aug; 75(8):1506-10. PubMed ID: 26929219
[TBL] [Abstract][Full Text] [Related]
3. Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial.
Devauchelle-Pensec V; Carvajal-Alegria G; Dernis E; Richez C; Truchetet ME; Wendling D; Toussirot E; Perdriger A; Gottenberg JE; Felten R; Fautrel BJ; Chiche L; Hilliquin P; Le Henaff C; Dervieux B; Direz G; Chary-Valckenaere I; Cornec D; Guellec D; Marhadour T; Nowak E; Saraux A
JAMA; 2022 Sep; 328(11):1053-1062. PubMed ID: 36125471
[TBL] [Abstract][Full Text] [Related]
4. Correction of abnormal B-cell subset distribution by interleukin-6 receptor blockade in polymyalgia rheumatica.
Carvajal Alegria G; Devauchelle-Pensec V; Renaudineau Y; Saraux A; Pers JO; Cornec D
Rheumatology (Oxford); 2017 Aug; 56(8):1401-1406. PubMed ID: 28431111
[TBL] [Abstract][Full Text] [Related]
5. Ultrasonography and magnetic resonance imaging changes in patients with polymyalgia rheumatica treated by tocilizumab.
Huwart A; Garrigues F; Jousse-Joulin S; Marhadour T; Guellec D; Cornec D; Gouillou M; Saraux A; Devauchelle-Pensec V
Arthritis Res Ther; 2018 Jan; 20(1):11. PubMed ID: 29370856
[TBL] [Abstract][Full Text] [Related]
6. Effects of inflammation and treatment on bone turnover and bone mass in polymyalgia rheumatica.
Dolan AL; Moniz C; Dasgupta B; Li F; Mackintosh C; Todd P; Corrigall V; Panayi GS
Arthritis Rheum; 1997 Nov; 40(11):2022-9. PubMed ID: 9365092
[TBL] [Abstract][Full Text] [Related]
7. Tocilizumab for polymyalgia rheumatica: report of two cases and review of the literature.
Macchioni P; Boiardi L; Catanoso M; Pulsatelli L; Pipitone N; Meliconi R; Salvarani C
Semin Arthritis Rheum; 2013 Aug; 43(1):113-8. PubMed ID: 23433960
[TBL] [Abstract][Full Text] [Related]
8. Localized Myofascial Inflammation Revealed by Magnetic Resonance Imaging in Recent-onset Polymyalgia Rheumatica and Effect of Tocilizumab Therapy.
Laporte JP; Garrigues F; Huwart A; Jousse-Joulin S; Marhadour T; Guellec D; Cornec D; Devauchelle-Pensec V; Saraux A
J Rheumatol; 2019 Dec; 46(12):1619-1626. PubMed ID: 30877202
[TBL] [Abstract][Full Text] [Related]
9. Contribution of bone turnover markers to the variation in bone mineral density: a study in Vietnamese men and women.
Nguyen LT; Nguyen UDT; Nguyen TDT; Ho-Pham LT; Nguyen TV
Osteoporos Int; 2018 Dec; 29(12):2739-2744. PubMed ID: 30196375
[TBL] [Abstract][Full Text] [Related]
10. The effect of tocilizumab on bone mineral density, serum levels of Dickkopf-1 and bone remodeling markers in patients with rheumatoid arthritis.
Briot K; Rouanet S; Schaeverbeke T; Etchepare F; Gaudin P; Perdriger A; Vray M; Steinberg G; Roux C
Joint Bone Spine; 2015 Mar; 82(2):109-15. PubMed ID: 25557658
[TBL] [Abstract][Full Text] [Related]
11. Wnt Inhibitors and Bone Turnover Markers in Patients With Polymyalgia Rheumatica and Acute Effects of Glucocorticoid Treatment.
Fassio A; Adami G; Idolazzi L; Giollo A; Viapiana O; Vantaggiato E; Benini C; Rossini M; Dejaco C; Gatti D
Front Med (Lausanne); 2020; 7():551. PubMed ID: 33015101
[No Abstract] [Full Text] [Related]
12. Value of (18)F-FDG PET/CT for therapeutic assessment of patients with polymyalgia rheumatica receiving tocilizumab as first-line treatment.
Palard-Novello X; Querellou S; Gouillou M; Saraux A; Marhadour T; Garrigues F; Abgral R; Salaün PY; Devauchelle-Pensec V
Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):773-9. PubMed ID: 26753600
[TBL] [Abstract][Full Text] [Related]
13. Reference intervals for serum concentrations of three bone turnover markers for men and women.
Michelsen J; Wallaschofski H; Friedrich N; Spielhagen C; Rettig R; Ittermann T; Nauck M; Hannemann A
Bone; 2013 Dec; 57(2):399-404. PubMed ID: 24076251
[TBL] [Abstract][Full Text] [Related]
14. Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone.
Garnero P; Thompson E; Woodworth T; Smolen JS
Arthritis Rheum; 2010 Jan; 62(1):33-43. PubMed ID: 20039425
[TBL] [Abstract][Full Text] [Related]
15. Effects of denosumab on bone turnover markers in postmenopausal osteoporosis.
Eastell R; Christiansen C; Grauer A; Kutilek S; Libanati C; McClung MR; Reid IR; Resch H; Siris E; Uebelhart D; Wang A; Weryha G; Cummings SR
J Bone Miner Res; 2011 Mar; 26(3):530-7. PubMed ID: 20839290
[TBL] [Abstract][Full Text] [Related]
16. Tocilizumab monotherapy for polymyalgia rheumatica: A prospective, single-center, open-label study.
Chino K; Kondo T; Sakai R; Saito S; Okada Y; Shibata A; Kurasawa T; Okuyama A; Takei H; Amano K
Int J Rheum Dis; 2019 Dec; 22(12):2151-2157. PubMed ID: 31625288
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory Markers are Quickly Improved by Tocilizumab in Early Polymyalgia Rheumatica and Might Predict Early Response to Interleukin-6 Blockade.
Carvajal Alegria G; Cornec DYK; Renaudineau Y; Saraux A; Devauchelle-Pensec V
Rheumatol Ther; 2021 Jun; 8(2):751-760. PubMed ID: 33745124
[TBL] [Abstract][Full Text] [Related]
18. Signs of a Glucose- and Insulin-Independent Gut-Bone Axis and Aberrant Bone Homeostasis in Type 1 Diabetes.
Hartmann B; Longo M; Mathiesen DS; Hare KJ; Jørgensen NR; Esposito K; Deacon CF; Vilsbøll T; Holst JJ; Knop FK
J Clin Endocrinol Metab; 2023 Dec; 109(1):e259-e265. PubMed ID: 37466204
[TBL] [Abstract][Full Text] [Related]
19. Bone turnover in untreated polymyalgia rheumatica.
Barnes TC; Daroszewska A; Fraser WD; Bucknall RC
Rheumatology (Oxford); 2004 Apr; 43(4):486-90. PubMed ID: 14722347
[TBL] [Abstract][Full Text] [Related]
20. Tocilizumab in isolated polymyalgia rheumatica: A systematic literature review.
Akiyama M; Kaneko Y; Takeuchi T
Semin Arthritis Rheum; 2020 Jun; 50(3):521-525. PubMed ID: 32107035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
